Copley Acquisition And Ignite Proteomics Mutually Terminate Business Combination Agreement Effective October 9, 2026; Termination Agreement Ends All Rights And Obligations Under Business Combination Agreement Except Certain Sections

Copley Acquisition and Ignite Proteomics have mutually terminated their business combination agreement effective October 9, 2026. The termination agreement concludes all rights and obligations under the original business combination agreement, with the exception of certain specified sections. This decision was filed with the SEC.